Price $64.77 |
Market Cap
1.02B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
71.1
|
P/B
3.1
|
P/S
2.23
|
Dividend %
-
|
|
P/CF
404.0
|
P/FCF
20.0
|
Op. Cash Flow
58.7K
|
FCF
2.7
|
|
Op. Margin
8.20%
|
Net Margin
1.40%
|
ROE
2.10%
|
ROI
6.80%
|
|
ROA
1.50%
|
EPS Growth
374.60%
|
Current Ratio
3.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 12.7M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $3.57 | - | - | 464.2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $2.40 | - | - | 26M | Strong Buy |
| BioScrip Inc (BIOS) | $3.53 | - | - | 464.8M | Strong Buy |
| Medical Transcription Billing (MTBC) | $4.53 | - | - | 48.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
